Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

The emergence of the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health challenge of global concern since December 2019, when the virus was recognized in Wuhan, the capital city of Hubei province in China and epicenter of the COVID-19 epidemic. Given the novelty of C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Clin Risk Manag
Autori principali: Hamdy, Sherif M, Abdel-Naseer, Maged, Shehata, Hatem S, Hassan, Amr, Elmazny, Alaa, Shalaby, Nevin M, Abokrysha, Noha T, Kishk, Nirmeen A, Nada, Mona A F, Ahmed, Sandra M, Hegazy, Mohamed I, Mekkawy, Doaa, Mourad, Husam S, Abdelalim, Ahmed, Berger, Thomas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398889/
https://ncbi.nlm.nih.gov/pubmed/32801722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S257714
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi